Gilead Sciences, Inc. (NASDAQ:GILD) shares have dipped 22% this past year, as investors are skeptical as to whether the biotech giant’s HCV franchise …
Credit Suisse analyst Alethia Young posits, “To acquire or to be acquired, that is the question for Biogen Inc (NASDAQ:BIIB).” Until an answer …
Analyst Alethia Young from Credit Suisse gave her thoughts on Gilead Sciences, Inc. (NASDAQ:GILD) and its place in HCV.
In a research report released Friday, Deutsche Bank analyst Alethia Young maintained a Buy rating on Intercept Pharma (NASDAQ:ICPT) with a price target …
In a research report released Monday, Deutsche Bank analyst Alethia Young maintained a Buy rating on Regulus Therapeutics (NASDAQ:RGLS) with a $30 price target, …
In a research note issued today, Deutsche Bank analyst Alethia Young maintained a Buy rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $17 price target, following numerous presentations of …
In a research report sent to investors today, Deutsche Bank analyst Alethia Young initiated coverage on Avanir Pharmaceuticals (NASDAQ:AVNR) with a Buy rating and a $17 price …
In a research report issued today, Deutsche Bank analyst Alethia Young reiterated a Buy rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with a price target …
